-
Rare Disease Search Adds Large Language Model A.I.
A company offering a search engine to help diagnose rare diseases is integrating generative models from Open AI into its artificial intelligence algorithms.
-
Infographic – Climate Start-Ups Still Gaining Venture Funds
Despite a sharp downturn in venture dollars from 2021, new climate and weather forecasting companies continue to attract investments at historically high rates.
-
Collaboration to Boost Rare Disease Clinical Trials
An organization seeking new uses for today’s drugs and a contract research company aim to increase the number of clinical trials for rare diseases testing already approved drugs.
-
Quantum Technology Start-Up Accelerator Unveiled
A business incubator is underway to help start-up enterprises in Denmark working in quantum technologies, particularly with defense-related applications.
-
$15M Alternative Chicken, Fish Challenge Finalists Named
An international challenge competition seeking sustainable but realistic alternatives to natural chicken and fish protein named its six finalist teams.
-
Digital Diabetes System Shown to Cut Health Care Use
A study of people with type 2 diabetes shows those using a digital diabetes management system made fewer hospital visits than non-users over a 12-month period.
-
Computational Drug Discovery Company Acquires A.I. Businesses
Two companies using artificial intelligence to advance biotechnology and design new therapies are merging with a computational-engineering drug discovery enterprise.
-
Infographic – Psychedelics Funding Coming Down
Technology intelligence company CB Insights says this week that psychedelic therapies and services are generating little interest among venture investors this year, with only nine deals totaling $21 million.
-
Crispr Therapy Shown to Remove E. Coli in Gut
New research with lab animals shows gene-edited viruses can target and remove harmful E. coli bacteria from the gut, including strains usually resistant to antibiotics.
-
Trial Underway Testing Psychedelic Drug for Depression
The first participant in a clinical trial received a dose of a psychedelic therapy, assessing the experimental compound in people with treatment resistant depression.